Autophagy-mediating microRNAs in cancer chemoresistance

Yuanming Jing1, Wenqing Liang2, Jian Liu3

  • 1Department of Gastrointestinal Surgery, Shaoxing People's Hospital, Shaoxing Hospital, Zhejiang University School of Medicine, Shaoxing, 312000, Zhejiang Province, People's Republic of China.

Cell Biology and Toxicology
|September 3, 2020
PubMed

Insights

MicroRNAs (miRNAs) regulate cancer chemoresistance by modulating autophagy. This study reviews how miRNAs impact chemotherapy effectiveness through autophagy pathways, offering insights into overcoming treatment failure.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Chemoresistance causes over 90% of cancer-related deaths, highlighting an urgent need for novel therapeutic strategies.
  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and play critical roles in cancer development and progression, including chemoresistance.
  • Autophagy, a cellular degradation process, has a dual role in chemotherapy response, either promoting resistance or inducing cell death.

Purpose of the Study:

  • To review the intricate mechanisms of chemoresistance in cancer.
  • To elucidate the multifaceted roles of miRNAs in cancer, particularly in the context of chemoresistance.
  • To explore the regulatory interplay between miRNAs and autophagy in modulating cancer cell response to chemotherapy.

Main Methods:

  • Comprehensive literature search on chemoresistance mechanisms.
  • Analysis of studies investigating the role of miRNAs in cancer.
  • Review of research focusing on miRNA-mediated regulation of autophagy in chemoresistance.

Main Results:

  • MicroRNAs are key regulators of chemoresistance, influencing multiple signaling pathways.
  • Autophagy can either confer resistance or sensitivity to chemotherapy agents, depending on the cellular context.
  • MicroRNAs modulate chemoresistance by targeting key components of the autophagy pathway.

Conclusions:

  • Understanding the miRNA-autophagy axis is crucial for developing effective strategies against chemoresistant cancers.
  • Targeting specific miRNAs or autophagy pathways holds promise for overcoming chemotherapy resistance.
  • Further research into this complex regulatory network may lead to improved cancer treatment outcomes.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.6K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K